NASDAQ:BLU BELLUS Health (BLU) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$14.74▼$14.7550-Day Range$14.42▼$14.7552-Week Range$6.38▼$14.76Volume3.45 million shsAverage Volume3.08 million shsMarket Capitalization$1.87 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get BELLUS Health alerts: Email Address Ad Market JARYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviation wave.Explore their Financial Opportunity Today About BELLUS Health Stock (NASDAQ:BLU)BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Read More Ad Market JARYour Ticket to the Future $75B Air Mobility Market Boom?Looking for the next big investment opportunity? This company could be your chance to catch the electric aviation wave.Explore their Financial Opportunity Today BLU Stock News HeadlinesAugust 29, 2024 | msn.comFlorida Blue patients worried about future coverage in the midst of Baptist Health negotiationsAugust 29, 2024 | bizjournals.comInspiring health: How AZ Blue goes beyond financial support to help local communities thrive (video)September 12, 2024 | Deal Maker (Ad)Invest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.August 21, 2024 | yahoo.comBlue Algae health alert issued for Lake Jessup, according to officialsAugust 15, 2024 | msn.com‘People’s lives are at stake:’ Contract negotiations continue between Baptist Health and Florida BlueAugust 15, 2024 | msn.comBaptist Health, Florida Blue must reach agreement to protect health of all in JacksonvilleAugust 1, 2024 | msn.comWhy Daylight Computer is focusing on health-focused blue light-free tabletsAugust 1, 2024 | yahoo.comWe Tested (and Rated!) All the Accent Chairs at Blu DotSeptember 12, 2024 | Deal Maker (Ad)Invest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges as demand ramps up. The market for this type of fuel is projected to grow 1,500% by 2030. Invest before this investment round closes on 9/18.May 25, 2024 | yahoo.comHealth department warning of blue-green algae bloom in West Palm areaMay 19, 2024 | morningstar.comValbiotis SA ALVALApril 26, 2024 | markets.businessinsider.comBlueprint Medicines: Buy Rating Affirmed on BLU-808 Prospects and Strong Ayvakit Sales ForecastMarch 21, 2024 | msn.comDeal reached between Dignity Health, Arizona Blue Cross Blue ShieldMarch 4, 2024 | msn.comThe effects of 'blue light' on human health are still unclear, says panelJanuary 4, 2024 | msn.comGlowing blue waves off Orange County coast make for thrilling start to New YearDecember 21, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Bluebird Bio (BLUE), United Therapeutics (UTHR)September 21, 2023 | forbes.comCBD Dosage: How Much Should You Take?June 28, 2023 | fool.comBellus Health (NASDAQ: BLU)See More Headlines Receive BLU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today9/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:BLU CUSIPN/A CIK1259942 Webwww.bellushealth.com Phone(450) 680-4500Fax45-0680-4501Employees74Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-76,080,000.00 Net Margins-578,586.63% Pretax Margin-578,226.56% Return on Equity-24.27% Return on Assets-23.14% Debt Debt-to-Equity RatioN/A Current Ratio33.42 Quick Ratio33.42 Sales & Book Value Annual Sales$15,000.00 Price / Sales124,613.93 Cash FlowN/A Price / Cash FlowN/A Book Value$3.09 per share Price / Book4.77Miscellaneous Outstanding Shares126,812,000Free Float96,162,000Market Cap$1.87 billion OptionableNot Optionable Beta0.19 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Roberto Francesco Bellini (Age 43)Pres, CEO & Director Comp: $790.35kMr. Ramzi Benamar (Age 50)Chief Financial Officer Comp: $650.48kDr. Andreas Orfanos FFPM (Age 64)M.B.B.Ch, MBA, Chief Operating Officer Comp: $417.58kDr. Denis Garceau Ph.D. (Age 66)Chief Scientific Officer Comp: $496.56kDr. Catherine M. Bonuccelli M.D. (Age 65)Chief Medical Officer Comp: $741.66kMr. Daniel MatthewsDirector of Investor Relations & CommunicationsMr. Tony Matzouranis (Age 50)Chief Bus. Officer Mr. Sebastien Roy (Age 47)Corp. Sec. More ExecutivesKey CompetitorsLianBioNASDAQ:LIANPHAXIAM TherapeuticsNASDAQ:PHXMKaleido BiosciencesNASDAQ:KLDO9 Meters BiopharmaNASDAQ:NMTRPolarityTENASDAQ:PTEIQView All Competitors BLU Stock Analysis - Frequently Asked Questions How were BELLUS Health's earnings last quarter? BELLUS Health Inc. (NASDAQ:BLU) issued its earnings results on Wednesday, November, 10th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.07. BELLUS Health had a negative trailing twelve-month return on equity of 24.27% and a negative net margin of 578,586.63%. What other stocks do shareholders of BELLUS Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that BELLUS Health investors own include Big Lots (BIG), Party City Holdco (PRTY), Washington Prime Group (WPG), Akorn (AKRXQ), Akers Biosciences (AKER) and Akebia Therapeutics (AKBA). This page (NASDAQ:BLU) was last updated on 9/12/2024 by MarketBeat.com Staff From Our PartnersRecently listed NASDAQ firm is well positioned for growth with game-changing AI platform for e-commerce.With an innovative AI platform, one tiny but growing NASDAQ firm is ushering in a new e-commerce era and is tr...Smallcaps Daily | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | SponsoredTesla of the Skies?Remember when Tesla disrupted the auto industry? Buckle up, because they could have the potential to do the sa...Market JAR | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BELLUS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
